Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.85
-0.16-7.96%
Last update: Oct 13, 3:46 PM
$2.00
-0.01-0.5%
Pyxis Oncology Inc (PYXS) Stock Price, Quote, News & History
PYXSNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Pyxis Oncology (NASDAQ:PYXS) through any online brokerage.
Other companies in Pyxis Oncology’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Pyxis Oncology has a consensus price target of $8.80.
The stock price for Pyxis Oncology (NASDAQ: PYXS) is $1.85 last updated October 13, 2026 at 3:46 PM EDT.
There are no upcoming dividends for Pyxis Oncology.
Pyxis Oncology does not have any upcoming earnings scheduled.
There is no upcoming split for Pyxis Oncology.
Pyxis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
